Segall Bryant & Hamill, LLC Insmed Inc Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Insmed Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 170,859 shares of INSM stock, worth $18.7 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
170,859
Previous 139,045
22.88%
Holding current value
$18.7 Million
Previous $9.6 Million
35.78%
% of portfolio
0.21%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding INSM
# of Institutions
516Shares Held
194MCall Options Held
893KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$2 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.69 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.56 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$1.42 Billion0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$789 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $14.8B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...